07332582 is referenced by 21 patents and cites 11 patents.

The present invention provides to a humanized monoclonal antibody having immunostimulatory effects. This antibody binds specifically to B lymphoblastoid cells, induces proliferation and activation of peripheral blood lymphocytes, and is capable of eliciting an anti-tumor effect upon administration to subjects suffering from cancer.

Title
Humanized immunomodulatory monoclonal antibodies for the treatment of neoplastic disease or immunodeficiency
Application Number
10/994091
Publication Number
7332582 (B2)
Application Date
November 19, 2004
Publication Date
February 19, 2008
Inventor
Leah Klapper
Givataim
IL
Steven Tarran Jones
Radlett
GB
Britta Hardy
Tel Aviv
IL
Agent
Winston & Strawn
Assignee
Mor Research Applications
IL
CureTech
IL
IPC
G01N 33/574
C07H 21/04
C12N 5/06
A61K 39/395
C07K 16/00
C12P 21/04
C12P 21/08
View Original Source